International comparison of cost effectiveness of medical management strategies for nephrolithiasis

Urological Research

Volumn 33, Issue 3, 2005, Pages 223-230

  Lotan, Yair ^a   Cadeddu, Jeffrey A ^a   Pearle, Margaret S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Health economics; International comparison; Medical evaluation; Nephrolithiasis

Indexed keywords

ALLOPURINOL; CITRATE POTASSIUM; THIAZIDE DIURETIC AGENT;

ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; EMERGENCY WARD; EMPIRICISM; EXTRACORPOREAL LITHOTRIPSY; HEALTH CARE SYSTEM; HUMAN; MEDICAL LITERATURE; NEPHROLITHIASIS; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM; UNITED STATES; URETEROSCOPY;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; KIDNEY CALCULI; RECURRENCE;

EID: 21244440662     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-005-0463-9     Document Type: Article

References (19)

1. Pearle MS, Curhan GC, Calhoun EA (2004) Urolithiasis. In: Litwin MS, Saigal CS (eds) Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH publication no. 04-5512. US Government Publishing Office, Washington, p 3
2. Pearle MS, Roehrborn CG, Pak CY (1999) Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13: 679
3. Tiselius H-G (2000) Comprehensive metabolic evaluation of stone formers is cost effective. In: Rodgers AL, Hibbert BE, Hess B, Kahn SR, Preminger GM (eds) Urolithiasis 2000, Proceedings of the 9th International Symposium on Urolithiasis, Cape Town, South Africa. University of Cape Town Press Cape Town, p 349
4. Parks JH, Coe FL (1996) The financial effects of kidney stone prevention. Kidney Int 50: 1706
5. Robertson WG (2000) The economic case for the biochemical screening of stone patients. In: Rodgers AL, Hibbert BE, Hess B, Kahn SR, Preminger GM (eds) Urolithiasis 2000, Proceedings of the 9th International Symposium on Urolithiasis, Cape Town, South Africa. University of Cape Town Press Cape Town, p 403
6. Strohmaier WL, Hormann M (2000) Economic aspects of urolithiasis (U) and metaphylaxis (M) in Germany. In: Rodgers AL, Hibbert BE, Hess B, Kahn SR, Preminger GM (eds) Urolithiasis 2000, Proceedings of the 9th International Symposium on Urolithiasis, Cape Town, South Africa. University of Cape Town Press Cape Town, p 406
7. Chandhoke PS (2002) When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol 168: 937
8. Hosking DH, Erickson SB, Van den Berg CJ, Wilson DM, Smith LH (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130: 1115
9. Keeley FXJr, Tilling K, Elves A, Menezes P, Wills M, Rao N et al. (2001) Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int 87: 1
10. Glowacki LS, Beecroft ML, Cook RJ, Pahl D, Churchill DN (1992) The natural history of asymptomatic Urolithiasis. J Urol 147: 319
11. Streem SB, Yost A, Mascha E (1996) Clinical implications of clinically insignificant store fragments after extracorporeal shock wave lithotripsy. J Urol 155: 1186
12. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158: 2069
13. Lotan Y, Cadeddu JA, Roehrborn CG, Pak CYC, Pearle MS (2004) Cost-effectiveness of medical management strategies of nephrolithiasis. J Urol 172: 2275
14. Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139: 679
15. Laerum E, Larsen S (215) Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215: 383
16. Wilson DR, Strauss AL, Manuel MA (1984) Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis. Urol Res 12: 39
17. Robertson WG, Peacock M, Selby PL et al. (1985) A mulit-centre trial to evaluate three treatments for idiopathic calcium stone disease: a preliminary report. In: Schwille O, Smith L, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum Press, New York, p 545
18. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 162: 27
19. Yagisawa T, Chandhoke PS, Fan J (1999) Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 161: 1449